Stéphane Bermon1. 1. Monaco Institute for Sports Medicine and Surgery, Monaco, and Université Côte d'Azur, LAMHESS, Nice, France.
Abstract
PURPOSE OF REVIEW: During the last decades androgens have been used illicitly by athletes of both genders. Because of some obvious ethical limitations, mechanisms underlying the performance-enhancing effects of these hormone or drugs, as well as the magnitude of their effects, have been poorly addressed. This review aims to combine findings from field and from the laboratory to provide new insights into the ergogenic properties of endogenous or exogenous androgens on female athletes. RECENT FINDINGS: Results obtained from recent neuropsychological studies indicated that testosterone, and not the sex chromosomes, is responsible for the sexual differentiation of visuospatial neural activation. These findings could explain how males and hyperandrogenic females benefit from androgens performance-enhancing effects in sports where visuospatial abilities are closely linked to better performance. Another study conducted on elite female athletes showed that, in some athletic events, where muscle power is of critical importance, individuals with the highest free testosterone concentration significantly outperformed competitors with the lowest free testosterone concentration. SUMMARY: In some sport events, female athletes with high or very high androgen levels (whether it is from endogenous or exogenous origin) have an estimated competitive benefit of 2-5% over those with androgen levels within the normal female range. These findings are to be taken into account in the actual controversy about eligibility of females with hyperandrogenism to compete in women's sports.
PURPOSE OF REVIEW: During the last decades androgens have been used illicitly by athletes of both genders. Because of some obvious ethical limitations, mechanisms underlying the performance-enhancing effects of these hormone or drugs, as well as the magnitude of their effects, have been poorly addressed. This review aims to combine findings from field and from the laboratory to provide new insights into the ergogenic properties of endogenous or exogenous androgens on female athletes. RECENT FINDINGS: Results obtained from recent neuropsychological studies indicated that testosterone, and not the sex chromosomes, is responsible for the sexual differentiation of visuospatial neural activation. These findings could explain how males and hyperandrogenic females benefit from androgens performance-enhancing effects in sports where visuospatial abilities are closely linked to better performance. Another study conducted on elite female athletes showed that, in some athletic events, where muscle power is of critical importance, individuals with the highest free testosterone concentration significantly outperformed competitors with the lowest free testosterone concentration. SUMMARY: In some sport events, female athletes with high or very high androgen levels (whether it is from endogenous or exogenous origin) have an estimated competitive benefit of 2-5% over those with androgen levels within the normal female range. These findings are to be taken into account in the actual controversy about eligibility of females with hyperandrogenism to compete in women's sports.
Authors: Holly L McClung; Barry A Spiering; P Matthew Bartlett; Leila A Walker; Elizabeth M Lavoie; Diana P Sanford; Karl E Friedl Journal: Med Sci Sports Exerc Date: 2022-05-27
Authors: Deaglan McCullough; Richard Webb; Kevin J Enright; Katie E Lane; Jim McVeigh; Claire E Stewart; Ian G Davies Journal: Rev Endocr Metab Disord Date: 2020-12-02 Impact factor: 6.514
Authors: Blair R Hamilton; Giscard Lima; James Barrett; Leighton Seal; Alexander Kolliari-Turner; Guan Wang; Antonia Karanikolou; Xavier Bigard; Herbert Löllgen; Petra Zupet; Anca Ionescu; Andre Debruyne; Nigel Jones; Karin Vonbank; Federica Fagnani; Chiara Fossati; Maurizio Casasco; Demitri Constantinou; Bernd Wolfarth; David Niederseer; Andrew Bosch; Borja Muniz-Pardos; José Antonio Casajus; Christian Schneider; Sigmund Loland; Michele Verroken; Pedro Manonelles Marqueta; Francisco Arroyo; André Pedrinelli; Konstantinos Natsis; Evert Verhagen; William O Roberts; José Kawazoe Lazzoli; Rogerio Friedman; Ali Erdogan; Ana V Cintron; Shu-Hang Patrick Yung; Dina C Janse van Rensburg; Dimakatso A Ramagole; Sandra Rozenstoka; Felix Drummond; Theodora Papadopoulou; Paulette Y O Kumi; Richard Twycross-Lewis; Joanna Harper; Vasileios Skiadas; Jonathan Shurlock; Kumpei Tanisawa; Jane Seto; Kathryn North; Siddhartha S Angadi; Maria Jose Martinez-Patiño; Mats Borjesson; Luigi Di Luigi; Michiko Dohi; Jeroen Swart; James Lee John Bilzon; Victoriya Badtieva; Irina Zelenkova; Juergen M Steinacker; Norbert Bachl; Fabio Pigozzi; Michael Geistlinger; Dimitrios G Goulis; Fergus Guppy; Nick Webborn; Bulent O Yildiz; Mike Miller; Patrick Singleton; Yannis P Pitsiladis Journal: Sports Med Date: 2021-03-24 Impact factor: 11.928
Authors: Peter H Sönksen; Richard I G Holt; Walailuck Böhning; Nishan Guha; David A Cowan; Christiaan Bartlett; Dankmar Böhning Journal: Clin Diabetes Endocrinol Date: 2018-02-07